Through ClientSite you can filter variants and download your reports
Enhancing biological knowledge through proteomics
Measures the concentration of thousands of human proteins using minimal sample quantities.
More Data. Less effort.
Thanks to its proprietary Proximity Extension Assay (PEA) technology, Olink® Explore enables accurate and simultaneous quantification of hundreds to thousands of protein biomarkers secreted in human body fluids. The Olink platform offers the accuracy and sensitivity of manual techniques with minimal sample requirements.
The incorporation of NGS allows greater scalability of samples and biomarkers analyzed simultaneously without affecting data quality and reducing costs.
.
Explore 384-plex panels
Olink Explore technology consists of eight Explore 384-plex panels focused on diseases and biological processes. This flexible and scalable offer uses approximately 1 µL of blood sample per 384-plex panel.
You can test all panels simultaneously (Explore 3072) or focus on one or more of the Explore 384-plex panels.
Olink® Explore 384 Cardiometabolic I and II
Olink® Explore 384 Inflammation I and II
Olink® Explore 384 Neurology I and II
Olink® Explore 384 Oncology I and II
Olink Explore panels contain biomarkers to answer key research questions, covering as many metabolic pathways and functions as possible.
SELECTED
BIOMARCKERS
3072 OLINK® EXPLORE PANELS
Endless possibilities on a single platform
Olink Explore is a high-value platform for studies involved in drug development, clinical research or basic research aiming to perform large-scale discovery proteomics studies.
What makes Olink® Explore different?
The study of the secretome has been limited by the lack of tools to accurately and precisely analyze its complexity. Olink Explore provides an answer to all these limitations:
High sensibility
Outstanding specificity
>3.000 biomarkers
Minimal sample requirements (<1 μl para 384-plex, <6 μl para 3072-plex)
Broad dynamic range (femtograms to milligrams)
Innovación para el descubrimiento de biomarcadores proteicos y el análisis de proteínas
Unprecedented power
Olink Explore has emerged as an essential technology in personalized medicine for the identification and monitoring of biomarkers for early diagnosis, prognosis, improved patient stratification, and follow-up of treatment response (>1,400 publications).
Supporting the complete drug development process
Research
Discovery of a therapeutic target
Preclinical research
In vivo/in vitro testing
Clinical development
Phase 1
Dosage and safety
Phase 2
Efficacy/side effects
Phase 3
Effect/adverse event
Phase 4
Post-market surveillance
Olink® Explore panels
We capture genuine biological information with proven specificity. At any scale.
Cardiometabolic II
367
analytes
Cardiometabolic
369
analytes
Inflammation
368
analytes
Inflammation II
369
analytes
Oncology
368
analytes
Oncology II
368
analytes
Neurology
367
analytes
Neurology II
367
analytes
Explore 3072
2943
analytes
Our workflow
First session
Analysis service contract and dispatch of the sample form
Samples delivery
Sample processing
Results analysis
Report submission
Do you have any questions?
Request a budget here!